Current Diagnostic Criteria for Neurocysticercosis.

Taenia solium cysticercosis diagnosis epidemiology epilepsy neurocysticercosis

Journal

Research and reports in tropical medicine
ISSN: 1179-7282
Titre abrégé: Res Rep Trop Med
Pays: New Zealand
ID NLM: 101562656

Informations de publication

Date de publication:
2021
Historique:
received: 20 05 2021
accepted: 20 07 2021
entrez: 19 8 2021
pubmed: 20 8 2021
medline: 20 8 2021
Statut: epublish

Résumé

Neurocysticercosis (NCC) causes significant neurological morbidity around the world, and is the most common preventable factor for epilepsy in adults. It is endemic in most developing countries, and also diagnosed with some frequency in industrialized countries because of travel and migration. The clinical manifestations of NCC are extremely variable and may include almost any neurological symptom, depending on the number of lesions, location, size and evolutive stage of the infecting parasitic larvae and the immune response of the host. Thus, the diagnosis of NCC relies mostly on neuroimaging and immunological tests. Despite being a disease with a known etiology, the lack of specificity of clinical manifestations and auxiliary examinations makes its diagnosis difficult. In an attempt for developing a standard diagnosis approach, a chart of diagnostic criteria for NCC was initially published in 1996, and revised in 2001 and 2017. This chart of diagnostic criteria systematized the diagnosis of NCC and became widely used worldwide. This manuscript describes the structure of the chart, the principles behind the changes for each revision, as well as the context of its use and potential for improvement.

Identifiants

pubmed: 34408532
doi: 10.2147/RRTM.S285393
pii: 285393
pmc: PMC8364393
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

197-203

Subventions

Organisme : FIC NIH HHS
ID : D43 TW001140
Pays : United States

Informations de copyright

© 2021 Guzman and Garcia.

Déclaration de conflit d'intérêts

H.G. contributed to the 2001 and the 2017 versions of the diagnostic criteria for neurocysticercosis revised in this manuscript. The authors report no other conflicts of interest in this work.

Références

J Parasitol. 1996 Feb;82(1):7-10
pubmed: 8627504
Korean J Parasitol. 2013 Feb;51(1):43-9
pubmed: 23467388
Neurology. 1992 Feb;42(2):389-92
pubmed: 1736171
Vet Immunol Immunopathol. 1991 Aug;29(1-2):69-78
pubmed: 1949584
Rev Infect Dis. 1988 Nov-Dec;10(6):1075-87
pubmed: 3060939
J Clin Neurosci. 2014 Jun;21(6):1066-8
pubmed: 24291479
Br Med J. 1934 Jan 6;1(3809):13-4
pubmed: 20777985
World Neurosurg. 2017 Sep;105:1043.e11-1043.e13
pubmed: 28711539
Prog Clin Parasitol. 1994;4:77-116
pubmed: 7948938
Clin Microbiol Rev. 2020 May 27;33(3):
pubmed: 32461308
Neurol India. 2004 Jun;52(2):171-7
pubmed: 15269463
Pathog Glob Health. 2012 Sep;106(5):286-98
pubmed: 23265553
Continuum (Minneap Minn). 2018 Oct;24(5, Neuroinfectious Disease):1489-1511
pubmed: 30273249
Clin Infect Dis. 2013 Oct;57(7):e154-9
pubmed: 23788241
Acta Neurol Belg. 2018 Sep;118(3):509-511
pubmed: 28849540
BMC Neurol. 2014 Jul 01;14:138
pubmed: 24980846
Neurology. 2002 Apr 23;58(8):1315; author reply 1315-6
pubmed: 11971116
J Neurol Sci. 1996 Oct;142(1-2):1-6
pubmed: 8902711
PLoS Negl Trop Dis. 2012;6(10):e1851
pubmed: 23094118
Clin Infect Dis. 2018 Jan 6;66(2):282-288
pubmed: 29020381
Expert Rev Neurother. 2011 Aug;11(8):1175-83
pubmed: 21797658
Acute Med. 2016;15(2):79-83
pubmed: 27441309
Top Magn Reson Imaging. 2014 Jun;23(3):191-8
pubmed: 24887694
Clin Neurol Neurosurg. 1995 Aug;97(3):256-8
pubmed: 7586860
Brain Res Bull. 2019 Feb;145:30-38
pubmed: 30170188
Neuroradiology. 1997 Jan;39(1):12-8
pubmed: 9121640
Hawaii J Med Public Health. 2017 Jun;76(6):152-155
pubmed: 28607832
J Neurol Sci. 2017 Jan 15;372:202-210
pubmed: 28017213
Parasit Vectors. 2014 Jan 16;7:12
pubmed: 24433262
Lancet Neurol. 2014 Dec;13(12):1202-15
pubmed: 25453460
J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):247-9
pubmed: 7876864
Epilepsia. 2005 Jan;46(1):124-31
pubmed: 15660778
Neuroimaging Clin N Am. 2012 Nov;22(4):659-76
pubmed: 23122261
Nat Rev Neurol. 2016 Sep 28;12(10):560-1
pubmed: 27677966
Epilepsia. 2015 Feb;56(2):177-83
pubmed: 25534640
Am J Trop Med Hyg. 2017 Sep;97(3):653-657
pubmed: 28820689
J Clin Microbiol. 2018 Aug 27;56(9):
pubmed: 29875195
Cleve Clin J Med. 2017 Mar;84(3):196-198
pubmed: 28322682
Epilepsy Behav. 2017 Nov;76:158-162
pubmed: 28606690
Acta Trop. 2003 Jun;87(1):71-8
pubmed: 12781380
Pathog Glob Health. 2012 Sep;106(5):299-304
pubmed: 23265554
Neurology. 2001 Jul 24;57(2):177-83
pubmed: 11480424
Am J Trop Med Hyg. 2005 Jun;72(6):837-9
pubmed: 15964973
Ann Neurol. 2016 Sep;80(3):434-42
pubmed: 27438337

Auteurs

Carolina Guzman (C)

Center for Global Health, Universidad Peruana Cayetano Heredia, Lima, Perú.

Hector H Garcia (HH)

Center for Global Health, Universidad Peruana Cayetano Heredia, Lima, Perú.
Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Perú.

Classifications MeSH